| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.00041 | 1 |